4/A: Strata Critical Medical Form 4 Amendment

Amir Cohen amends prior Form 4 filing to correct transaction code for tax withholding related to restricted stock unit vesting.

Summary

• This filing is an amendment to a previously filed Form 4 by Amir Cohen, Chief Accounting Officer of Strata Critical Medical, Inc.
• The amendment corrects a transaction code used in the original filing on June 10, 2026, related to a disposal of Class A common stock on June 8, 2026.
• The original filing incorrectly used the 'S' code; the amended filing uses the 'F' code to accurately reflect that shares were withheld by the Issuer to satisfy tax withholding obligations.
• These tax obligations arose in connection with the vesting of restricted stock units.
• The number of shares involved in this transaction was 4,655, with a reported price of $5.87.
• Following this transaction, Amir Cohen beneficially owns 146,608 shares of Class A common stock directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it corrects a procedural error and confirms compliance with regulations, rather than indicating new financial performance or strategic shifts.

Positives

• Correction of a filing error to ensure accurate reporting of beneficial ownership and transactions.
• Confirmation that the transaction was handled in accordance with Rule 16b-3 of the Securities Exchange Act of 1934.
• The underlying transaction (vesting of restricted stock units and tax withholding) is a standard and expected event for executive compensation.

Negatives

• Initial error in transaction coding on a Form 4 filing, requiring an amendment.

Risks

• Potential for scrutiny or questions from the SEC regarding the initial error in the Form 4 filing, although it appears to be a clerical correction.
• The need for amendments can sometimes create minor confusion or perception issues among investors if not clearly communicated.

Future Outlook

This filing is an amendment to correct a previous filing and does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• "The Shares were in fact withheld by the Issuer to satisfy tax withholding obligations in connection a vesting event in a transaction approved in accordance with Rule 16b-3 of the Securities Exchange Act of 1934, as amended."
• "Footnote 1 to the Original Form correctly described the transaction as 'shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.'"
• "Accordingly, the reporting person is hereby amending the Original Form to correctly show the 'F' code in Column 3 of Table I."
• "The information set forth in the Original Form was correct in all other respects."

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insiders and amendments, while not ideal, are common for correcting administrative errors. The core transaction relates to executive compensation, a standard practice in the healthcare and medical device industry.

Stakeholder Impact

• Shareholders: The amendment clarifies a transaction, ensuring transparency in insider holdings. It does not introduce new financial information that would directly impact share price.
• Employees: The underlying transaction relates to employee (executive) compensation (vesting of RSUs), a standard component of their remuneration.
• Management: The Chief Accounting Officer is responsible for accurate financial reporting, and this amendment addresses a correction in that process.

Next Steps

• Ensure all SEC filings are meticulously reviewed for accuracy before submission to avoid future amendments.

Key Dates

Keywords

Form 4, SEC Filing, Strata Critical Medical, Amir Cohen, Beneficial Ownership, Stock Withholding, Tax Withholding, Restricted Stock Units, Amendment, SRTA